Cabaletta Bio, Inc.
CABA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $239 | $94 | $69 | $114 |
| - Cash | $60 | $146 | $132 | $164 |
| + Debt | $26 | $25 | $29 | $16 |
| Enterprise Value | $205 | -$27 | -$34 | -$35 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$44 | -$44 | -$35 | -$31 |
| % Margin | – | – | – | – |
| Net Income | -$45 | -$45 | -$36 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.44 | -0.73 | -0.73 | -0.65 |
| % Growth | 39.7% | 0% | -12.3% | – |
| Operating Cash Flow | -$35 | -$30 | -$31 | -$23 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$35 | -$31 | -$32 | -$23 |